Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer-Reference-Cited by-同舟云学术

Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer

Published:2020-05 Issue:3 Volume:21 Page:247-254
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Xia Hui,Xue Xingyang,Ding Huaxin,Ou Qiuxiang,Wu Xue,Nagasaka Misako,Shao Yang W.,Hu Xingsheng,Ou Sai-Hong Ignatius

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007

2. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

3. Further advances in the management of anaplastic lymphoma kinase–mutated non–small-cell lung cancer;Ou;J Clin Oncol,2017

4. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance;Schram;Nat Rev Clin Oncol,2017

5. Tyrosine kinase gene rearrangements in epithelial malignancies;Shaw;Nat Rev Cancer,2013

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NTRK gene fusion testing and management in lung cancer;Cancer Treatment Reviews;2024-06

2. Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan;Cancer Medicine;2024-06

3. NTRK3-Rearranged Prostatic Acinar Adenocarcinoma: Report of a Patient and Review of the Literature;International Journal of Surgical Pathology;2024-05-21

4. ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature;Clinical Lung Cancer;2024-05

5. Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report;Frontiers in Oncology;2024-04-18